Abstract

The interleukin (IL)-12 family of cytokines, including IL12 and IL 23, play an important role in driving aberrant Th1 and Th17 immune responses in patients with Crohn’s disease (CD).

Tags

Brazikumab, Crohn's Disease, Guselkumab, Mirikizumab, Pathology, Rizankizumab, Therapy, Ustekinumab

Read More